ATRA — Atara Biotherapeutics Share News
0.000.00%
Last trade - 00:00- $94.70m
- $127.81m
- $120.77m
U.S. STOCKS ON THE MOVE-Netflix, Reddit, L3Harris
U.S. STOCKS ON THE MOVE-Prologis, Space stocks, Evolus
U.S. STOCKS ON THE MOVE-D.R. Horton, Moderna, Warner Bros Discovery
Atara Biotherapeutics falls after FDA puts clinical hold on cancer therapy trials
US FDA puts clinical hold on Atara's trials for cancer cell therapies (updated)
Brief: Atara Biotherapeutics Provides Update On Clinical Programs For Ebvallo™ And Ata3219
US FDA puts clinical hold on Atara's trials for cancer cell therapies
U.S. STOCKS ON THE MOVE-Freshworks, Flowco, Target
U.S. STOCKS ON THE MOVE-Southwest Airlines, Target, UnitedHealth
Atara Biotherapeutics slumps after FDA declines to approve cancer therapy
US FDA declines to approve Atara Biotherapeutics' cancer therapy (updated)
Brief: Atara Biotherapeutics Provides Regulatory and Business Update on EBVALLOTM (tabelecleucel)
US FDA declines to approve Atara Biotherapeutics' cancer therapy
Atara Biotherapeutics Inc reports results for the quarter - Earnings Summary
Brief: Atara Biotherapeutics Q3 EPS USD -2.93
Atara Biotherapeutics Inc expected to post a loss of $1.93 a share - Earnings Preview
Atara Biotherapeutics Inc expected to post a loss of $1.93 a share - Earnings Preview
Atara Biotherapeutics Inc expected to post a loss of $1.93 a share - Earnings Preview
Brief: Atara Biotherapeutics- Appointed Eric Hyllengren To Serve As Chief Operating Officer, In Addition To Role As CFO